A Quote by Barton Gellman

Throughout the early and mid-1990s, the Clinton administration debated the merits of paying for AIDS testing and counseling of vulnerable populations overseas. — © Barton Gellman
Throughout the early and mid-1990s, the Clinton administration debated the merits of paying for AIDS testing and counseling of vulnerable populations overseas.
Those of us who lived through the worst of the HIV/AIDS epidemic from the early 1980s through the mid-1990s have a very special spot in our heart for home-based health care.
Unemployment determination in a modern economy was the main subject area of my research from the mid-1960s to the end of the 1970s and again from the mid-1980s to the early 1990s.
I have lived my whole life just outside Youngstown, Ohio. We watched the steel mills close and 50,000 jobs disappear in the late 1970s. We watched businesses move overseas throughout the 1990s and early 2000s.
I know that historically our foundation has had great relations with all the administrations.[Bill] Clinton administration did a lot of outreach. The greatest rise in U.S. foreign aid was under the [George] Bush administration, that's where we got the AIDS initiative, which is called PEPFAR.
I can remember in the late 1980s and early 1990s how many men with AIDS I saw everywhere in Key West. There were hospices and medical supply stores geared to people with AIDS. It seemed that every sick man who could afford it had headed for the warmth and the tranquillity and the gay-friendliness of the island.
Certainly the support for research in HIV/AIDS was good in the Clinton administration, good in the Bush administrations. It just was.
I used to smoke marijuana. But I'll tell you something: I would only smoke it in the late evening. Oh, occasionally the early evening, but usually the late evening - or the mid-evening. Just the early evening, midevening and late evening. Occasionally, early afternoon, early mid-afternoon, or perhaps the late-midafternoon. Oh, sometimes the early-mid-late-early morning. . . But never at dusk!
I believe that President Clinton considered the legal merits of the arguments for the pardon as he understood them, and he rendered his judgment, wise or unwise, on the merits.
Drug warriors' staunch opposition to needle exchanges to prevent the spread of HIV in addicts delayed the programs' widespread introduction in most states for years. A federal ban on funding for these programs wasn't lifted until 2009. Contrast this with what happened in the U.K. At the peak of the AIDS epidemic in the mid-1990s, the HIV infection rate in IV drug users in the U.K. was about 1%. In New York City, the American epicenter, that figure was 50%. The British had introduced widespread needle exchange in 1986. That country had no heterosexual AIDS epidemic.
It's fashionable to speak about vulnerable populations in medicine and public policy, but it's harder to find a more vulnerable population than those who are dying.
During the terrorist regime in Haiti in the 1990s, the CIA, under the administration of Bill Clinton, was reporting to Congress that oil shipments had been blocked from entering Haiti. That was just a lie. I was there. You could see the oil terminals being built and the ships coming in.
In the early and mid 1990s, every musician I knew was obsessed with Helium. The 'Pirate Prude' EP and 'Pat's Trick' played on repeat at nearly every gathering I attended. And we didn't just listen to these records - we discussed them, the worlds they opened, novelistic and strange.
In the mid-1980s to the early 1990s I was writing songs not because I particularly liked what I was doing, but because I was desperately trying to get back into the charts. I really didn't enjoy it. I didn't like the music I was making, I wasn't proud of it, like I have been before or since.
Not long ago, the term 'business model' was not exactly on the tip of everyone's tongue. Then, in the early to mid-1990s, 'business model' became a catchphrase that described how a company makes money or saves money.
Throughout his presidency, Clinton made a point of getting close - physically and emotionally - to the people whose problems his administration was working to solve.
If you ask yourself who is paying for pharmaceutical innovation today, the answer is that it's the more affluent populations paying for still-patented advanced medicines at the pharmacy, for comprehensive insurance coverage or for a national health system.
This site uses cookies to ensure you get the best experience. More info...
Got it!